Direct Relief is a medical assistance organization that is active in all 50 states and approximately 100 other countries each year, focused on providing access to health services and essential medications for persons who need but cannot afford them. The organization serves functionally as a medical distributor and provides in-kind donations of medications, vaccines, medical equipment, and medical supplies to qualified nonprofit partners and government organizations upon request to address unmet needs that exist in areas of chronic need and also when emergencies occur. Direct Relief also provides financial grants to qualified nonprofit organizations. In 2020, the organization reports its assistance included delivering 2,600 tons (5.2 million lbs.) of medical commodities, including 223 million defined daily doses of medications and more than 30 million units of personal protective equipment (PPE), through 27,600 shipments valued at $1.4 billion to 2,833 organizations. The organization also disbursed $46.6 million in cash grants. In addition, Direct Relief conducts ongoing research and publishes a range of topic-specific maps regarding health issues such as obstetric fistula and the social vulnerability of persons in emergency-affected areas.
For the year ended June 30, 2020, Direct Relief's program expenses were:
| International programs |
$1,224,336,000 |
| USA programs |
$331,269,000 |
| Total Program Expenses: |
$1,555,605,000 |
-
Chief Executive
Thomas E. Tighe, President and Chief Executive Officer
-
Compensation*
$564,634
-
Chair of the Board
Pamela Gann
-
Chair's Profession / Business Affiliation
Professor of Legal Studies, Claremont McKenna; Former President, Claremont McKenna
-
Board Size
18
-
Paid Staff Size
111
*2019 compensation includes annual salary and, if applicable, benefit plans, expense accounts, and other allowances.
Method(s) Used:
Grant proposals, Internet, Planned giving arrangements, Cause- related marketing (affinity credit cards, consumer product sales, etc.)
Fundraising costs were less than 1% of related contributions. (Related contributions, which totaled $1,997,622,000, are donations received as a result of fundraising activities.)
This organization is tax-exempt under section 501(c) (3) of the Internal Revenue Code.It is eligible to receive contributions deductible as charitable donations for federal income tax purposes.
The following information is based on Direct Relief's audited financial statements - consolidated for the year ended June 30, 2020.
| Source of Funds |
| Donated pharmaceuticals, medical supplies, and equipment |
$1,821,478,000 |
| Business and foundation grants |
$105,163,000 |
| Contributions |
$61,691,000 |
| Workplace giving campaigns |
$4,384,000 |
| Contributed freight |
$2,679,000 |
| Investment income, net |
$2,316,000 |
| Donated professional services |
$1,349,000 |
| Contributed goods - other |
$864,000 |
| Special events |
$14,000 |
| Realized and unrealized loss on investments |
($964,000) |
| Total Income |
$1,998,974,000 |
- Programs: 100%
- Administrative: Less than 1%
- Fundraising: Less than 1%
| Total Income |
$1,998,974,000 |
| Program expenses |
$1,555,605,000 |
| Fundraising expenses |
$2,953,000 |
| Administrative expenses |
$5,867,000 |
| Other expenses |
$0 |
| Total expenses: |
$1,564,425,000 |
| Income in Excess of Expenses |
$434,549,000 |
| Beginning Net Assets |
$557,892,000 |
| Other Changes In Net Assets |
$0 |
| Ending Net Assets |
$992,441,000 |
| Total Liabilities |
$22,879,000 |
| Total Assets |
$1,015,320,000 |
Note: According to Direct Relief's audited financial statements for the year ended June 30, 2020, the organization received in-kind contributions totaling $1,826,370,000 in the form of pharmaceuticals, medical supplies and equipment ($1,821,478,000), contributed freight ($2,679,000), professional services ($1,349,000), and contributed goods - other ($864,000).